A Randomized, Double-blind, Placebo-controlled, Multicenter Trial, Assessing the Impact of Inclisiran on Major Adverse Cardiovascular Events in Participants With Established Cardiovascular Disease (VICTORION-2 PREVENT)
Lay Description
Category
- Heart, Vascular and Blood
- IRB Number
- 20220092HU
- NCT Number
- ct.gov registration not required
- Open to Enrollment
- Yes
Eligibility
- Eligible Ages
- Eligible Genders
- Accepts Healthy Volunteers
Inclusion Criteria
Exclusion Criteria
Study Design
Arm Groups
Study Contact
Andrea Hansis-diarte
+1 (210) 617-5300
hansisdiarte@uthscsa.edu
Italia Herrera
(210) 567-2687
herrerai1@uthscsa.edu
Edgar Infante
infantee@uthscsa.edu
Johnnie Jones
(210) 450-7277
jonesj21@uthscsa.edu
Lorannys Sanchez Tamarez
(210) 450-8332
sancheztamar@uthscsa.edu
Italia Herrera
(210) 567-2687
herrerai1@uthscsa.edu
Edgar Infante
infantee@uthscsa.edu
Principal Investigator
Carolina Solis-Herrera